Live feed07:00:00·1742dPRReleasevia QuantisnowCOMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugsByQuantisnow·Wall Street's wire, on your screen.CMPS· COMPASS Pathways PlcHealth Care